ELDN EBITDA Growth
Eledon Pharmaceuticals Inc · EBITDA Growth
ELDN EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-630.96%period ending
ELDN TTM EBITDA YoY % (-77.80% → -630.96%)
Year-over-year change
High-resolution chart · PNG
ELDN ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -630.956% | |
| -325.1675% | |
| -28.5557% | |
| -16,077.1429% | |
| 117.4478% | |
| 83.0391% | |
| 62.8807% | |
| 99.4901% | |
| 9.6399% | |
| -169.4557% | |
| -142.9722% | |
| -148.8413% | |
| -149.783% | |
| -7.1537% | |
| -7.0194% | |
| -14.742% | |
| -40.7345% | |
| -73.288% | |
| -129.1875% | |
| -181.8776% | |
| -161.5311% | |
| -72.9607% | |
| -14.2694% | |
| 26.8411% | |
| 37.9426% | |
| 22.2726% | |
| 0.3345% | |
| -40.9986% | |
| -53.4366% | |
| -10.8684% | |
| -7.2525% | |
| 21.4707% | |
| 17.2561% | |
| -91.627% | |
| 25.6499% | |
| 40.7778% | |
| 62.0831% | |
| 82.5062% | |
| 60.9807% | |
| 38.3764% | |
| -0.7499% | |
| -35.9081% | |
| -92.6198% | |
| -77.8835% | |
| -77.8004% |